Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.